Journal article · 2025 · Open access
Nanoparticle Drug Delivery System for Bioavailability Enchancement
Journal of chemical health risks · Published 9 May 2025
In brief
“Nanoparticle Drug Delivery System for Bioavailability Enchancement” is a 2025 journal article by Mansi Kailas Patil, published in Journal of chemical health risks. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at Journal of chemical health risks.
- Citations
- 0
- Authors
- 1
Abstract
Nanoparticle-based drug delivery systems have revolutionized the field of pharmaceutical sciences by providing a promising approach to enhance the bioavailability of poorly soluble drugs. By formulating drugs into nanoparticles, their solubility, stability, and permeability can be improved, leading to increased bioavailability and therapeutic efficacy. This review aims to provide a comprehensive overview of nanoparticle-based drug delivery systems, including lipid nanoparticles, polymeric nanoparticles, and inorganic nanoparticles, and their applications in enhancing the bioavailability of various drugs. The use of nanoparticles as drug delivery systems offers several advantages, including increased surface area, improved permeability, and targeted delivery. Nanoparticles can be designed to interact with biological membranes, enhancing the permeability of drugs across epithelial barriers. Additionally, nanoparticles can be engineered to target specific tissues or cells, reducing the distribution of drugs to non-target sites and increasing their bioavailability. Nanotechnology is the concept used in NDDS that enables a weight reduction of drug particles accompanied by an increase in stability and improved functionality. Various approaches such as nanosuspensions, liposomes, niosomes, nanoemulsions, cubosomes, solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), cyclodextrins, phytosome etc., are used for the enhancement of bioavailability. The present review focuses on the different approaches used for bioavailability enhancement along with their advantages and disadvantages.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Patil, M. K. (2025). Nanoparticle Drug Delivery System for Bioavailability Enchancement. Journal of chemical health risks. https://jchr.org/index.php/JCHR/article/view/8211
MLA 9
Patil, Mansi Kailas. “Nanoparticle Drug Delivery System for Bioavailability Enchancement.” Journal of chemical health risks, 2025. https://jchr.org/index.php/JCHR/article/view/8211.
Chicago
Patil, Mansi Kailas. 2025. “Nanoparticle Drug Delivery System for Bioavailability Enchancement.” Journal of chemical health risks. https://jchr.org/index.php/JCHR/article/view/8211.
Harvard
Patil, M. K. (2025) ‘Nanoparticle Drug Delivery System for Bioavailability Enchancement’, Journal of chemical health risks. Available at: https://jchr.org/index.php/JCHR/article/view/8211.
IEEE
M. K. Patil, “Nanoparticle Drug Delivery System for Bioavailability Enchancement,” Journal of chemical health risks, 2025.
BibTeX
@article{patil2025nanoparticle,
title = {{Nanoparticle Drug Delivery System for Bioavailability Enchancement}},
author = {Patil, Mansi Kailas},
journal = {Journal of chemical health risks},
year = {2025},
url = {https://jchr.org/index.php/JCHR/article/view/8211}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- nanoparticle drug delivery
- bioavailability enhancement
- poorly water-soluble drugs
- lipid nanoparticles
- polymeric nanoparticles
- inorganic nanoparticles
- nanoparticle suspensions
- liposomes
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Patil, M. K. (2025). Nanoparticle Drug Delivery System for Bioavailability Enchancement. Journal of chemical health risks. https://jchr.org/index.php/JCHR/article/view/8211
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of chemical health risks.
Who wrote this paper?
Mansi Kailas Patil.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.